A randomized non-inferiority clinical study to assess post-exposure prophylaxis by a new purified vero cell rabies vaccine (Rabivax-S) administered by intramuscular and intradermal routes.
Bose A, Munshi R, Tripathy RM, Madhusudana SN, Harish BR, Thaker S, Mahendra BJ, Gunale B, Gogtay NJ, Thatte UM, Mani RS, Manjunath K, George K, Yajaman AB, Sahai A, Dhere RM, Alex RG, Adhikari DD, Abhilash, Raghava V, Kumbhar D, Behera TR, Kulkarni PS.
Bose A, et al. Among authors: manjunath k.
Vaccine. 2016 Sep 14;34(40):4820-6. doi: 10.1016/j.vaccine.2016.08.005. Epub 2016 Aug 21.
Vaccine. 2016.
PMID: 27554534
Clinical Trial.